
23andMe Files for Chapter 11 Bankruptcy; CEO Resigns to Pursue Independent Bid
Genetic testing company 23andMe has filed for Chapter 11 bankruptcy protection in a move aimed at restructuring operations and facilitating a court-supervised asset sale. Co-founder Anne Wojcicki has stepped down as CEO to position herself as an independent bidder for the company’s assets. The filing follows ongoing financial challenges, a major 2023 data breach, and shifts in the consumer health tech space.
Fitbit and Quest Diagnostics Collaborate on Metabolic Health Study
Explore the collaboration between Fitbit and Quest Diagnostics in the WEAR-ME study, aiming to revolutionize metabolic health management using wearable tech and lab insights to prevent diabetes and heart disease. Discover how this study could change health monitoring.